financetom
Business
financetom
/
Business
/
B2Gold Prices $400 Million Convertible Notes Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
B2Gold Prices $400 Million Convertible Notes Offering
Jan 24, 2025 1:25 AM

03:58 AM EST, 01/24/2025 (MT Newswires) -- B2Gold ( BTG ) said late Thursday it has priced a $400 million offering of convertible senior unsecured notes due 2030.

The company also said it has granted initial purchasers a 15-day option to purchase up to $60 million worth of additional notes.

The notes will bear interest at an annual rate of 2.75% per annum and the initial conversion rate will be 315.2088 common shares of B2Gold ( BTG ) per $1,000 worth of notes, equivalent to a conversion price of around $3.17 per share or a premium of about 35% to the latest closing price, the company said.

The offering is expected to close Tuesday, the company said.

The company said it intends to use net proceeds from the offering for general corporate purposes.

In connection with the offering, B2Gold ( BTG ) said it entered into a cash-settled total return swap for about $50 million worth of shares with one of the initial debt purchasers.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
France's CFDT union may take strike action over Exxon job cuts
France's CFDT union may take strike action over Exxon job cuts
Sep 16, 2024
PARIS, Sept 16 (Reuters) - France's CFDT trade union said on Monday that it could join an ongoing strike by the CGT union at ExxonMobil's ( XOM ) Port Jerome refinery as talks with the company near a deadline. So far, the strike action has been limited to chemical workers after Exxon said it would shut down its steam cracker...
Update: Nuvalent Shares Jump After Trials of Lung Cancer Drugs Show 'Favorable Tolerability'
Update: Nuvalent Shares Jump After Trials of Lung Cancer Drugs Show 'Favorable Tolerability'
Sep 16, 2024
12:19 PM EDT, 09/16/2024 (MT Newswires) -- (Updates with stock move in the headline and first paragraph.) Nuvalent ( NUVL ) shares jumped 22% in recent Monday trading after the company said data from clinical studies of zidesamtinib and NVL-655 to treat patients with non-small cell lung cancer showed favorable tolerability. The company said Saturday the parallel phase 1/2 trials...
Gaucho Plans $1.6 Million Cost Reduction in Restructuring; Shares Rise
Gaucho Plans $1.6 Million Cost Reduction in Restructuring; Shares Rise
Sep 16, 2024
12:18 PM EDT, 09/16/2024 (MT Newswires) -- Gaucho Group Holdings ( VINO ) said Monday it expects to save $1.6 million over the next 12 months through a restructuring and cost reduction strategy. Over the past year, the company said it has realigned many operational roles and functions to Argentina from the US, benefiting from the more favorable cost of...
Ascendis Pharma's Rare Dwarfism Candidate Shows Promise In Trial, FDA Submission Expected Next Year
Ascendis Pharma's Rare Dwarfism Candidate Shows Promise In Trial, FDA Submission Expected Next Year
Sep 16, 2024
Ascendis Pharma A/S ( ASND ) released topline data on Monday from a trial that included 84 children with achondroplasia, a genetic disorder that causes dwarfism and disproportionate short stature. TransCon CNP (navepegritide), an investigational prodrug of C-type natriuretic peptide (CNP) administered once weekly and designed to provide sustained release and continuous exposure of active CNP. CNP regulates blood flow, blood...
Copyright 2023-2026 - www.financetom.com All Rights Reserved